Scarica l'app Stockscreener
8.96
2.17%
0.19
Dopo l'orario di chiusura:
8.95
-0.01
-0.11%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Viatris Inc Borsa (VTRS) Ultime notizie
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Viatris Inc. of Class Action Lawsuit and Upcoming DeadlinesVTRS - PR Newswire
Viatris Inc. (VTRS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
VIATRIS INC. (NASDAQ: VTRS) DEADLINE ALERT: Bernstein - GlobeNewswire
Contact The Gross Law Firm by June 3, 2025 Deadline to Join Class Action Against Viatris Inc.(VTRS) - PR Newswire
Investors in Viatris Inc. Should Contact Levi & Korsinsky Before June 3, 2025 to Discuss Your RightsVTRS - Stockhouse
VIATRIS (VTRS) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action by June 3, 2025 - TradingView
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ViatrisVTRS - GlobeNewswire
VTRS INVESTOR ALERT: A Class Action was filed against Viatris Inc. for Securities Fraud – Contact BFA Law before June 3 Deadline (NASDAQ:VTRS) - GlobeNewswire Inc.
2025-05-10 | VTRS LAWSUIT ALERT: Levi & Korsinsky Notifies Viatris Inc. Investors of a Class Action Lawsuit and Upcoming Deadline | NDAQ:VTRS | Press Release - Stockhouse
VIATRIS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Viatris Inc.VTRS - marketscreener.com
VTRS DEADLINE REMINDER: Viatris Inc. Investors are Reminded - GlobeNewswire
VTRS Investors: Robbins LLP Reminds Viatris Inc. Stockholders of the Class Action Lawsuit on Behalf of Investors - GlobeNewswire
VTRS Investors: Robbins LLP Reminds Viatris Inc. Stockholders of the Class Action Lawsuit on ... - Bluefield Daily Telegraph
Viatris Inc. Class Action: Levi & Korsinsky Reminds Viatris Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 3, 2025VTRS - Morningstar
Deadline Alert: Viatris Inc. (VTRS) Investors Who Lost - GlobeNewswire
Viatris Inc. Reports Q1 2025 Earnings and Outlook - TipRanks
Viatris, Inc. Earnings Call: Mixed Sentiments and Strategic Advances - TipRanks
Viatris Will File ‘Fast-Acting’ Meloxicam For FDA Approval This Year - insights.citeline.com
2025-05-08 | Viatris Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before June 3, 2025 to Discuss Your RightsVTRS | NDAQ:VTRS | Press Release - Stockhouse
Viatris Discloses Positive Data From 2 Drugs In Earnings Report, Stock SoarsViatris (NASDAQ:VTRS) - Benzinga
Viatris: Q1 Earnings Snapshot - The Washington Post
Contact Levi & Korsinsky by June 3, 2025 Deadline to Join Class Action Against Viatris ... - Eagle-Tribune
Viatris Q1 Earnings Exceed Wall Street Expectations, Company Raises Full-Year Profit Outlook: Retail’s Positive - Asianet Newsable
Viatris Q1 Earnings Review: Shares Are Up, Time To Sell (Rating Downgrade) (VTRS) - Seeking Alpha
Viatris Q1 Earnings and Revenues Beat Estimates, Stock Gains - TradingView
Viatris reports success in Phase 3 birth control patch study By Investing.com - Investing.com South Africa
Viatris’ new form of old pain drug scores in large trials - BioPharma Dive
VIATRIS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of ... - Bluefield Daily Telegraph
VIATRIS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Viatris Inc.VTRS - GlobeNewswire
Viatris Raises Profit Expectations Thanks To Chinese Demand - Finimize
Viatris (NASDAQ:VTRS) Reports Sales Below Analyst Estimates In Q1 Earnings, But Stock Soars 8% - Yahoo Finance
Earnings call transcript: Viatris Q1 2025 earnings miss forecasts, stock rises - Investing.com
Viatris Inc SEC 10-Q Report - TradingView
Viatris Reports Q1 2025 Financial Results and Pipeline Progress - TipRanks
Viatris rises as Q1 beat comes with late-stage trial wins - MSN
Viagra-maker Viatris beats quarterly estimates on demand for branded drugs in China - marketscreener.com
Viatris stock gains after Q1 beat (VTRS:NASDAQ) - Seeking Alpha
Viatris Q1 2025 slides: maintains guidance despite revenue decline, pipeline advances - Investing.com
Viatris stock gains on late-stage trial win (VTRS:NASDAQ) - Seeking Alpha
Viatris misses Q1 estimates, reaffirms 2025 outlook - Investing.com
Viatris reports success in Phase 3 birth control patch study - Investing.com
Viatris in charts: Generic sales drop 16% in Q1; revenue from Developed Markets falls 13% - Seeking Alpha
Viatris reports positive Phase 3 results for pain treatment MR-107A-02 - Investing.com
Viatris Reports First Quarter 2025 Results and Reaffirms 2025 Outlook - Viatris
Viatris stock rises on late-stage trial win (VTRS:NASDAQ) - Seeking Alpha
Viatris' pain drug meets main goals of two late-stage trials - marketscreener.com
Viatris Announces Positive Results from Phase 3 Study of Investigational XULANE LO™ Low Dose Patch for Birth Control in Women of Childbearing Potential - PR Newswire
Viatris Announces Positive Top-Line Results from Two Pivotal Phase 3 Studies of Novel Fast-Acting Meloxicam (MR-107A-02) for the Treatment of Moderate-to-Severe Acute Pain - PR Newswire
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of June 3, 2025 in Viatris Inc. LawsuitVTRS - PR Newswire
VIATRIS (VTRS) CLASS ACTION NOTICE: Berger Montague Encourages Investors With Substantial Losses to Contact the Firm By June 3, 2025 - TradingView
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
Viatris Can Sell Copies of Heron Nausea Drugs in 2032 After Deal - Bloomberg Law News
VTRS SECURITIES UPDATE: Viatris Inc. Investors with Losses - GlobeNewswire
Viatris Q1 Earnings Preview: Analysts expect profit to decline by about 27% - Seeking Alpha
Viatris Pens Aprepitant Settlement Agreement After Kabi Loses Initial Patent Case - insights.citeline.com
Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris - marketscreener.com
Class Action Filed Against Viatris Inc. (VTRS) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire
Viatris Announces Quarterly Dividend - Yahoo Finance
Do Wall Street Analysts Like Viatris Stock? - MSN
VIATRIS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY - GlobeNewswire
4.08%
2.72%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):